2026, thus far, has been characterized by one-or-two day swings back and forth. Underneath it all, the global stock market ...

Value stocks outperformed growth by a wide margin, while large-cap technology names increasingly served as sources of funds ...

Markets ended the week on a broadly positive note, closing out the third quarter with strength in technology, healthcare, and small caps. The first three quarters of 2025 are now complete, and markets ...

Equity markets finished the week with a mixed tone as leadership continued to rotate across sectors and styles. While large-cap growth and technology-oriented exposures showed modest weakness, select ...

ValuEngine is a subscription-based business intelligence, market and equity analysis firm that provides exclusive, customized research and analysis solutions directly to companies, investors, ...

ValuEngine is a subscription-based business intelligence, market and equity analysis firm that provides exclusive, customized research and analysis solutions directly to companies, investors, ...

ValuEngine lowered its rating on Surgery Partners’ shares from a “hold” to a “sell,” according to The Ledger Gazette. 1. Surgery Partners’ shares opened Nov. 24 trading at $8.60 per share. 2. The ...